- Grünenthal buys up Nebido from Bayer for $500 million FiercePharma
- Bayer to sell Nebido testosterone treatment in deal worth up to $500 mln Reuters.com
- Bayer sells testosterone drug rights to Grünenthal for €500m – pharmaphorum
- Bayer sells testosterone treatment to German company for $500M Endpoints News
- Bayer Sells Nebido To Grünenthal Amid Shift In Focus To Cell And Gene Pipeline Scrip
- View Full Coverage on Google News